WINTER GARDEN, Fla. (July 12, 2022) – Anton Health, a healthcare consultancy dedicated to connecting the industry’s brightest minds, today welcomes pharmaceutical market access veteran Elizabeth (Liz) Turner as Vice President.

Since 2004, Turner has been focused on expanding market access to important medications for patients. She has launched seven new products and indications across a wide range of therapeutic areas. Turner most recently served as Vice President of Global Market Access at Arena Pharmaceuticals, which was acquired by Pfizer in March. During her time at Arena, Liz built the market access function from scratch with a focus on the strategic development of disruptive platforms to launch a robust pipeline of novel products. Prior to her role at Arena, Turner spent more than a decade in sales leadership, marketing and market access representing the entire Amgen portfolio and launching several novel therapies. Turner was recognized for her work as both Coach of the Year and Marketer of the Year.

“Liz has consistently delivered exceptional results through her transformative approach and values-centric mindset,” said Anton Health President Leah Larweth. “We are thrilled Liz has chosen to bring her expertise, dedication and exceptional commitment to client service to our team at Anton Health.”

Turner earned her Master of Business Administration from the University of Central Florida. She is also a graduate of the University of South Florida where she earned a bachelor’s degree in mass communication.

To learn more about Anton Health, please visit


Anton Health is dedicated to helping clients solve the healthcare industry’s most complex challenges. Its expert advisory network offers a leading edge with unrivaled access to some of the brightest minds in healthcare. The Anton Health RapidApp™ offers on-demand, real-time market intelligence so you never miss an opportunity. Connect with Anton Health at


Read More

Limited Distribution Deals Announced

Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the press releases rarely

Send Us A Message

This website uses cookies to ensure you get the best experience on our website.